Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME - PubMed (original) (raw)
Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME
C Jamora et al. Proc Natl Acad Sci U S A. 1996.
Abstract
Stress protein GRP78/BiP is highly induced in progressively growing tumors and has recently been shown to exert a protective role against lysis by cytotoxic T cells and tumor necrosis factor in vitro. This raises the question whether the in vitro observed protective function of GRP78/BiP translates into the in vivo situation in which tumors grow progressively, killing the host. Herein we report that molecular inhibition of GRP78/BiP induction in the fibrosarcoma B/C10ME, while not affecting in vitro cell proliferation, causes a dramatic increase in apoptotic cell death upon Ca2+ depletion of the endoplasmic reticulum. When B/C10ME cells incapable of inducing GRP78/BiP are injected into mice, tumors are initially formed that, however, regress presumably due to a cytotoxic T-cell response demonstrable by a strong in vitro response to the tumor with spleen cells of regressor mice. Since sensitivity to apoptosis is key to tumor rejection, these results may point to new approaches to the therapy of cancer via regulation of stress protein GRP78/BiP.
Similar articles
- Suppression of stress protein GRP78 induction in tumor B/C10ME eliminates resistance to cell mediated cytotoxicity.
Sugawara S, Takeda K, Lee A, Dennert G. Sugawara S, et al. Cancer Res. 1993 Dec 15;53(24):6001-5. Cancer Res. 1993. PMID: 8261413 - Down-regulation of the endoplasmic reticulum chaperone GRP78/BiP by vomitoxin (Deoxynivalenol).
Yang GH, Li S, Pestka JJ. Yang GH, et al. Toxicol Appl Pharmacol. 2000 Feb 1;162(3):207-17. doi: 10.1006/taap.1999.8842. Toxicol Appl Pharmacol. 2000. PMID: 10652249 - GRP78 induction in cancer: therapeutic and prognostic implications.
Lee AS. Lee AS. Cancer Res. 2007 Apr 15;67(8):3496-9. doi: 10.1158/0008-5472.CAN-07-0325. Cancer Res. 2007. PMID: 17440054 Review. - ADP-ribosylation of the molecular chaperone GRP78/BiP.
Ledford BE, Leno GH. Ledford BE, et al. Mol Cell Biochem. 1994 Sep;138(1-2):141-8. doi: 10.1007/BF00928456. Mol Cell Biochem. 1994. PMID: 7898457 Review.
Cited by
- Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies.
Zuo WF, Pang Q, Zhu X, Yang QQ, Zhao Q, He G, Han B, Huang W. Zuo WF, et al. J Hematol Oncol. 2024 Sep 4;17(1):81. doi: 10.1186/s13045-024-01601-1. J Hematol Oncol. 2024. PMID: 39232809 Free PMC article. Review. - Protein-rich foods, sea foods, and gut microbiota amplify immune responses in chronic diseases and cancers - Targeting PERK as a novel therapeutic strategy for chronic inflammatory diseases, neurodegenerative disorders, and cancer.
Saaoud F, Lu Y, Xu K, Shao Y, Praticò D, Vazquez-Padron RI, Wang H, Yang X. Saaoud F, et al. Pharmacol Ther. 2024 Mar;255:108604. doi: 10.1016/j.pharmthera.2024.108604. Epub 2024 Feb 13. Pharmacol Ther. 2024. PMID: 38360205 Review. - Mechanism and Role of Endoplasmic Reticulum Stress in Osteosarcoma.
Zhu P, Li T, Li Q, Gu Y, Shu Y, Hu K, Chen L, Peng X, Peng J, Hao L. Zhu P, et al. Biomolecules. 2022 Dec 15;12(12):1882. doi: 10.3390/biom12121882. Biomolecules. 2022. PMID: 36551309 Free PMC article. Review. - The clinical relevance of unfolded protein response signaling in breast cancer.
Oshi M, Roy AM, Gandhi S, Tokumaru Y, Yan L, Yamada A, Endo I, Takabe K. Oshi M, et al. Am J Cancer Res. 2022 Jun 15;12(6):2627-2640. eCollection 2022. Am J Cancer Res. 2022. PMID: 35812054 Free PMC article. - GANAB and _N_-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review.
De Masi R, Orlando S. De Masi R, et al. Int J Mol Sci. 2022 Jul 1;23(13):7373. doi: 10.3390/ijms23137373. Int J Mol Sci. 2022. PMID: 35806376 Free PMC article. Review.
References
- Proc Natl Acad Sci U S A. 1977 Sep;74(9):3840-4 - PubMed
- Cancer Res. 1995 Jul 15;55(14):3016-21 - PubMed
- Proc Natl Acad Sci U S A. 1987 May;84(10):3278-82 - PubMed
- EMBO J. 1987 Aug;6(8):2223-32 - PubMed
- Cancer Res. 1987 Dec 15;47(24 Pt 1):6620-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous